KIMBERLY ROGERS: Open Payments
NPI 1336415983 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 39 payments from 16 companies in 2025. Trend: 2023 $650 · 2024 $900 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $153 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Actelion Pharmaceuticals US, Inc. | 3 | $57 |
| United Therapeutics Corporation | 2 | $47 |
| JAZZ PHARMACEUTICALS INC. | 2 | $37 |
| Fisher & Paykel Healthcare Inc | 2 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: NUCALA, WINREVAIR, Sunosi, GLASSIA, UPTRAVI, Tyvaso, TRELEGY ELLIPTA, XYWAV.
Industry payments across KY — which companies pay providers there.
